Haematology 2018

Survival outcome after a second malignancy n=1319 ; treatment period: 1969 and 1997; median fup 12 years.

No. of pts

5-yr survival estimate (%)

Median survival, yrs

Second malignancy

95% CI

All sites

181

38.1

(29.7-46.5)

3.2

Acute leukemia

23

4.9

(0.0-14.2)

0.4

NHL

24

49.6

(28.0, 71.2)

2.4

All solid tumors

131

42.1

(31.6, 52.5)

4.3

Breast

39

76.1

(57.4-94.8) Not yet reached

Lung

22

0.0

—

1.0

Gastrointestinal

24

12.4

(0-28.1)

1.9

Ng et al., Blood 2002